Impact of patient positioning on the efficacy and safety of doxycycline pleurodesis in malignant pleural effusion: a pilot randomized trial.

BMC Pulm MedAug 31, 2026 (epub)
Clinical ResearchPulmonologyOncology (Medical)Open access

Hieba Gamal Ezzelregal, Ahmed Mohamed Abdelsamad

✦ AI-curated · Sources linked

In 30 seconds

This pilot randomized trial evaluated the efficacy and safety of doxycycline pleurodesis in 40 patients with malignant pleural effusion, comparing a standard rotation protocol to a non-rotation approach. Both groups achieved identical pleurodesis success rates of 85% at one month (P > 0.99), suggesting that patient rotation may not be necessary for effective treatment.

Key findings

  • Pleurodesis success rates were 85% in both rotation and non-rotation groups.
  • Ultrasound-derived Pleural Adherence Scores were comparable: Mean 20.0 vs. 21.2 (P = 0.33).
  • No significant differences in pain scores, drainage duration, or complication rates were observed.

Why it matters

The findings suggest that omitting patient rotation during doxycycline pleurodesis may simplify the procedure without compromising efficacy or safety, potentially reducing patient discomfort and resource use.

Source

Published in BMC Pulm Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pulmonology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.